Predictors of stroke in patients with impaired glucose tolerance: results from the Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research trial. by Preiss, D, Giles, T, Thomas, L, Sun, J, Haffner, S, Holman, R, Standl, E, Mazzone, T, Rutten, G, Tognoni, G, Chiang, F, McMurray, J, Califf, R

Prediction of cardiovascular disease risk by cardiac biomarkers in 2 United Kingdom cohort studies by Welsh, P, Hart, C, Papacosta, O, Preiss, D, McConnachie, A, Murray, H, Ramsay, S, Upton, M, Watt, G, Whincup, P, Wannamethee, G, Sattar, N

Pooled safety analysis of evolocumab in over 6000 patients from double-blind and open-label extension studies by Toth, P, Descamps, O, Genest, J, Sattar, N, Preiss, D, Dent, R, Djedjos, C, Wu, Y, Geller, M, Uhart, M, Somaratne, R, Wasserman, S, for the PROFICIO Investigators

Effect of fenofibrate on progression of diabetic retinopathy by Preiss, D, Logue, J, Sammons, E, Zayed, M, Emberson, J, Wade, R, Wallendszus, K, Stevens, W, Cretney, R, Harding, S, Leese, G, Currie, G, Armitage, J

Empagliflozin lowers serum uric acid in chronic kidney disease: exploratory analyses from the EMPA-KIDNEY trial by Mayne, K, Sardell, R, Staplin, N, Judge, P, Zhu, D, Sammons, E, Emberson, J, Preiss, D, Landray, M, Baigent, C, Wanner, C, Haynes, R, Herrington, W

Frailty, multimorbidity and polypharmacy: exploratory analyses of the effects of empagliflozin from the EMPA-KIDNEY trial by Mayne, KM, Sardell, R, Staplin, N, Judge, P, Zhu, D, Sammons, E, Wanner, C, Emberson, J, Preiss, D, Landray, M, Baigent, C, Haynes, R, Herrington, W

Predictors of cardiovascular events in a contemporary population with impaired glucose tolerance: an observational analysis of the Nateglinide and Valsartan in impaired glucose tol... by Preiss, D, Thomas, L, Sun, J, Haffner, S, Holman, R, Standl, E, Leiter, L, Mazzone, T, Rutten, G, Tognoni, G, Martinez, F, Chiang, F, Califf, R, McMurray, J

Harmonization of large-scale, heterogeneous individual participant adverse event data from randomized trials of statin therapy by Emberson, J, Spata, E, Blackwell, L, Davies, K, Halls, H, Harper, C, Roddick, A, Samuel, N, Stevens, W, Wallendszus, K, Preiss, D, Collins, R, Baigent, C, Reith, C

Clinical and echocardiographic characteristics and cardiovascular outcomes according to diabetes status in patients with heart failure and preserved ejection fraction. A report fro... by Kristensen, S, Mogensen, U, Jhund, P, Petrie, M, Preiss, D, Win, S, Køber, L, McKelvie, R, Zile, M, Anand, I, Komajda, M, Gottdiener, J, Carson, P, McMurray, J

Effects of empagliflozin on fluid overload, weight and blood pressure in chronic kidney disease by Mayne, K, Haynes, R, Keane, D, Staplin, N, Judge, P, Preiss, D, Emberson, J, Dayanandan, R, Lee, R, Nolan, J, Omata, A, Landray, M, Baigent, C, Herrington, W

The sustained influence of metformin therapy on circulating GLP-1 levels in individuals with and without type 2 diabetes by Preiss, D, Dawed, A, Welsh, P, Heggie, A, Jones, A, Dekker, J, Koivula, R, Hansen, T, DIRECT consortium, Stewart, C, Holman, R, Franks, P, Walker, M, Pearson, E, Sattar, N

Comparison between high-sensitivity cardiac troponin T and cardiac troponin I in a large general population cohort by Welsh, P, Preiss, D, Shah, A, McAllister, D, Briggs, A, Boachie, C, McConnachie, A, Hayward, C, Padmanabhan, S, Welsh, C, Woodward, M, Campbell, A, Porteous, D, Mills, N, Sattar, N

Comparison between high-sensitivity cardiac troponin T and cardiac troponin I in a large general population cohort by Welsh, P, Preiss, D, Shah, A, McAllister, D, Briggs, A, Boachie, C, McConnachie, A, Hayward, C, Padmanabhan, S, Welsh, C, Woodward, M, Campbell, A, Porteous, D, Mills, N, Sattar, N

Effects of empagliflozin on progression of chronic kidney disease: a prespecified secondary analysis from the empa-kidney trial by Staplin, N, Haynes, R, Herrington, W, Judge, P, Emberson, J, Preiss, D, Mayne, K, Sammons, E, Zhu, D, Hill, M, Stevens, W, Wallendszus, K, Landray, M, Baigent, C, The EMPA-KIDNEY Collaborative Group

Comparison of PCSK9 inhibitor evolocumab vs ezetimibe in statin-intolerant patients: Design of the goal achievement after utilizing an anti-PCSK9 antibody in statin-intolerant subj... by Nissen, SE, Dent-Acosta, RE, Rosenson, RS, Stroes, E, Sattar, N, Mancini, GBJ, Ballantyne, CM, Catapano, A, Gouni-Berthold, I, Stein, EA, Xue, A, Wasserman, SM, Scott, R, Preiss, D, Thompson, PD

Effects of statin therapy on diagnoses of new-onset diabetes and worsening glycaemia in large-scale randomised blinded statin trials: an individual participant data meta-analysis by Reith, CA, Preiss, D, Blackwell, L, Emberson, J, Davies, K, Halls, H, Harper, C, Holland, L, Wilson, K, Roddick, A, Clarke, R, Mihaylova, B, Armitage, J, Collins, R, Baigent, C, Barnes, E

Effect of mineralocorticoid receptor antagonists on proteinuria and progression of chronic kidney disease: a systematic review and meta-analysis by Currie, G, Taylor, A, Fujita, T, Ohtsu, H, Lindhardt, M, Rossing, P, Boesby, L, Edwards, N, Ferro, C, Townend, J, van den Meiracker, A, Saklayen, M, Oveisi, S, Jardine, A, Delles, C, Preiss, D, Mark, P

Risk Related to Pre–Diabetes Mellitus and Diabetes Mellitus in Heart Failure With Reduced Ejection Fraction by Kristensen, S, Preiss, D, Jhund, P, Squire, I, Cardoso, J, Merkely, B, Martinez, F, Starling, R, Desai, A, Lefkowitz, M, Rizkala, A, Rouleau, J, Shi, V, Solomon, S, Swedberg, K, Zile, M, McMurray, J, Packer, M

Patient and public involvement and engagement in the ASCEND PLUS trial: reflections from the design of a streamlined and decentralised clinical trial by El-Nayir, M, Wijesurendra, R, Preiss, D, Mafham, M, Tsiotos, L, Islam, S, Whitehouse, A, Wilkinson, S, Freeman, H, Lee, R, Brudlo, W, Bobby, G, Jenkins, B, Humphrey, R, Mallorie, A, Toal, A, Barker, EC, Moylan, D, Thomson, G, Davies, F, Khan, H, Allotey, I, Dickie, S, Roberts, J

Interpretation of the evidence for the efficacy and safety of statin therapy by Collins, R, Reith, C, Emberson, J, Armitage, J, Baigent, C, Blackwell, L, Blumenthal, R, Danesh, J, Smith, G, DeMets, D, Evans, S, Law, M, MacMahon, S, Martin, S, Neal, B, Poulter, N, Preiss, D, Ridker, P, Roberts, I, Rodgers, A, Sandercock, P, Schulz, K, Sever, P, Simes, J, Smeeth, L, Wald, N, Yusuf, S, Peto, R